This target was approved using a streamlined target validation route exclusive to small and medium-sized enterprises (SMEs). https://docs.sbtiservices.com/resources/FAQsforSMEs.pdf N-Power Medicine commits to maintain zero scope 1 and scope 2 emissions through 2031, and to measure and reduce its scope 3 emissions from a 2024 base year.